荷兰儿童癌症幸存者研究(DCCSS)-LATER 2 肾脏分析:儿童癌症幸存者的长期肾小球功能障碍
荷兰全国性横断面队列研究纳入1024例儿童癌症幸存者和500例年龄性别匹配的对照,评估长期肾小球功能障碍。幸存者中肾小球滤过率低于60 ml/min/1.73m²者占3.7%,对照为0;白蛋白尿在幸存者中占16.2%,对照为1.2%。肾切除、腹部放疗、异环磷酰胺和顺铂>500 mg/m²是慢性肾脏病的危险因素。
要点
- 幸存者中3.7%肾小球滤过率<60 ml/min/1.73m²,对照为0;10例幸存者出现肾衰竭。
- 慢性肾脏病(按年龄阈值)在幸存者中占6.6%,对照为0.2%;白蛋白尿(尿白蛋白/肌酐比>3 mg/mmol)在幸存者中占16.2%,对照为1.2%。
- 肾切除、腹部放疗、异环磷酰胺和顺铂>500 mg/m²是慢性肾脏病的危险因素;全身照射、腹部放疗>30 Gy和异环磷酰胺是白蛋白尿的危险因素。
核心结论
- 儿童癌症幸存者长期肾小球功能障碍和白蛋白尿的患病率高于一般人群对照,接触已识别高危因素者需终身监测肾小球功能。
研究设计与样本
- 荷兰儿童癌症幸存者研究(DCCSS)-LATER 2 肾脏分析,全国性横断面队列研究,纳入1024例确诊后≥5年、研究时年龄≥18岁、1963-2001年间接受肾切除、腹部放疗、全身照射、顺铂、卡铂、异环磷酰胺、高剂量环磷酰胺或造血干细胞移植治疗的幸存者,以及500例来自Lifelines前瞻性人群队列的年龄和性别匹配对照。
主要发现
- 幸存者中位年龄32.0岁(四分位距26.6-37.4),肾小球滤过率<60 ml/min/1.73m²者占3.7%,对照为0;10例幸存者出现肾衰竭。
- 按年龄阈值的慢性肾脏病(肾小球滤过率<40岁<75、40-65岁<60、>65岁<40)在幸存者中占6.6%,对照为0.2%。
- 白蛋白尿(尿白蛋白/肌酐比>3 mg/mmol)在幸存者中占16.2%,对照为1.2%。
- 多变量分析显示慢性肾脏病的危险因素为肾切除(比值比3.7,95%置信区间2.1-6.4)、腹部放疗(1.8,1.1-2.9)、异环磷酰胺(2.9,1.9-4.4)和顺铂>500 mg/m²(7.2,3.4-15.2)。
- 白蛋白尿的危险因素为全身照射(2.3,1.2-4.4)、腹部放疗>30 Gy(2.6,1.4-5.0)和异环磷酰胺(1.6,1.0-2.4);高血压和随访≥30年增加肾小球功能障碍风险。
临床怎么用
- 作者认为,对接触上述已识别高危因素的幸存者,需终身监测肾小球功能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This investigation aimed to evaluate glomerular dysfunction among childhood cancer survivors in comparison with matched controls from the general population. In the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis, a nationwide cross-sectional cohort study, 1024 survivors five or more years after diagnosis, aged 18 or more years at study, treated between 1963-2001 with nephrectomy, abdominal radiotherapy, total body irradiation, cisplatin, carboplatin, ifosfamide, high-dose cyclophosphamide or hematopoietic stem cell transplantation participated. In addition, 500 age- and sex-matched controls from Lifelines, a prospective population-based cohort study in the Netherlands, participated. At a median age of 32.0 years (interquartile range 26.6-37.4), the glomerular filtration rate was under 60 ml/min/1.73m2 in 3.7% of survivors and in none of the controls. Ten survivors had kidney failure. Chronic kidney disease according to age-thresholds (glomerular filtration rate respectively under 75 for age under 40, under 60 for ages 40-65, and under 40 for age over 65) was 6.6% in survivors vs. 0.2% in controls. Albuminuria (albumin-to-creatinine ratio over3 mg/mmol) was found in 16.2% of survivors and 1.2% of controls. Risk factors for chronic kidney disease, based on multivariable analyses, were nephrectomy (odds ratio 3.7 (95% Confidence interval 2.1-6.4)), abdominal radiotherapy (1.8 (1.1-2.9)), ifosfamide (2.9 (1.9-4.4)) and cisplatin over 500 mg/m2 (7.2 (3.4-15.2)). For albuminuria, risk factors were total body irradiation (2.3 (1.2-4.4)), abdominal radiotherapy over 30 Gy (2.6 (1.4- 5.0)) and ifosfamide (1.6 (1.0-2.4)). Hypertension and follow-up 30 or more years increased the risk for glomerular dysfunction. Thus, lifetime monitoring of glomerular function in survivors exposed to these identified high risk factors is warranted.
引用
- Kooijmans ECM, van der Pal HJH, Pluijm SMF, et al. The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors. Kidney Int. 2022. PMID: 35772499. doi:10.1016/j.kint.2022.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。